The relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: Insights from a meta-analysis

scientific article published on 18 May 2015

The relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: Insights from a meta-analysis is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1177/1470320315585908
P698PubMed publication ID25990649

P2093author name stringXi Huang
Dan Hu
Qingxiang Wang
Chengfu Cai
Hualing Yang
Linyang Ye
Yiqing Rao
P2860cites workAngiotensin-converting enzyme (ACE) I/D genotype and renal ACE gene expressionQ44152987
Population-based versus hospital-based controls: are they comparable?Q46199440
Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women.Q51567963
The association between ACE polymorphism and risk of colorectal cancer in a Chinese population.Q54353921
Angiotensin-converting enzyme gene insertion/deletion polymorphism in patients with chronic pancreatitis and pancreatic cancer.Q54365845
The angiotensin I-converting enzyme gene insertion/deletion polymorphism is linked to early gastric cancer.Q54626140
On the comparability of population-based and hospital-based case-control studiesQ58873527
Cancer-associated fibroblasts in digestive tumorsQ27022816
MicroRNA-155 expression has prognostic value in patients with non-small cell lung cancer and digestive system carcinomasQ27027033
Meta-analysis in clinical trialsQ27860779
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statementQ27860868
Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in CaucasiansQ28391605
Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics.Q33865150
An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levelsQ34262228
The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patientsQ36012552
Influence of angiotensin I-converting enzyme gene polymorphism on hepatocellular carcinoma risk in ChinaQ36836530
Angiotensin-converting enzyme inhibitor therapy and colorectal cancer riskQ37634491
The ACE insertion/deletion polymorphism and risk of cancer, a review and meta-analysis of the literatureQ37852060
Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer: a nested case-control study.Q43651829
P433issue4
P304page(s)1306-1313
P577publication date2015-05-18
P1433published inJournal of the Renin-Angiotensin-Aldosterone SystemQ6296180
P1476titleThe relationship between angiotensin-converting enzyme gene insertion/deletion polymorphism and digestive cancer risk: Insights from a meta-analysis
P478volume16

Reverse relations

cites work (P2860)
Q42635975Angiotensin-Converting Enzyme Gene Deletion Polymorphism is Associated with Lymph Node Metastasis in Colorectal Cancer Patients in a Chinese Population.
Q45590471Association of insertion-deletions polymorphisms with colorectal cancer risk and clinical features.
Q38734603Up-Regulation of Angiotensin-Converting Enzyme (ACE) Enhances Cell Proliferation and Predicts Poor Prognosis in Laryngeal Cancer

Search more.